3,4-dihydroxyphenylacetic acid has been researched along with 1-methyl-4-phenylpyridinium in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (28.57) | 18.7374 |
1990's | 34 (48.57) | 18.2507 |
2000's | 13 (18.57) | 29.6817 |
2010's | 3 (4.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cano, J; Machado, A; Santiago, M; Venero, JL | 1 |
Bagchi, SP | 1 |
de Vries, JB; Rollema, H; Santiago, M; Westerink, BH | 1 |
Caliguri, EJ; Johannessen, JN | 1 |
Bradbury, AJ; Costall, B; Jenner, PG; Kelly, ME; Marsden, CD; Naylor, RJ | 1 |
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PG; Marsden, CD; Naylor, RJ; Testa, B | 1 |
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PJ; Marsden, CD; Naylor, RJ | 1 |
Arai, Y; Kinemuchi, H; Kisara, K; Matsumura, T; Sakuma, I; Satoh, N; Tadano, T | 1 |
De Vries, J; Kranenborg, G; Kuhr, WG; Rollema, H; Van den Berg, C | 1 |
Chiueh, CC; Miyake, H | 1 |
de Vries, JB; Hofsteede, RM; Tuntler, J; Westerink, BH | 1 |
Alexander, GM; Castagnoli, N; Grothusen, JR; Matos, FF; Rollema, H | 1 |
Daigle, M; Di Paolo, T; Harnois, C; Marcotte, G | 1 |
Booth, RG; Castagnoli, N; Johnson, EA; Rollema, H; Trevor, AJ; Wu, EY | 1 |
Carlsson, A; Ekman, A; Engel, J; Magnusson, T; Pileblad, E; Snape, BM | 1 |
Duvoisin, RC; Heikkila, RE; Nicklas, WJ | 1 |
Heavens, RP; McBride, CS; Sirinathsinghji, DJ | 1 |
Booth, RG; Castagnoli, N; Rollema, H | 1 |
Chang, GD; Ramirez, VD | 2 |
Arora, PK; Harik, SI; Iacofano, LA; Sayre, LM | 1 |
Cohen, G; Mytilineou, C | 1 |
Damsma, G; de Vries, JB; Rollema, H; Tuntler, J; Westerink, BH | 1 |
Clavier, RM; Foulks, JG; Jones, K; Perry, TL; Wall, RA; Wright, JM; Yong, VW | 1 |
Cano, J; Machado, A; Santiago, M | 2 |
Corsini, GU; Fascetti, F; Fornai, F; Maggio, R; Vaglini, F | 1 |
Ambrosio, S; Bartrons, R; Calopa, M; Espino, A; Llorens, J; Rodriguez-Farré, E | 1 |
Albores, R; Collins, MA; Gearhart, D; Kindel, G; Neafsey, EJ; Raikoff, K; Tamayo, F | 1 |
Andersen, JK; Beal, MF; Breakefield, XO; Frim, DM; Isacson, O | 1 |
Ambrosio, S; Baron, S; Mahy, N; Perez, V; Unzeta, M | 1 |
Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM | 1 |
Giovanni, A; Heikkila, RE; Sieber, BA; Sonsalla, PK | 1 |
Giovanni, A; Heikkila, RE; Sonsalla, PK | 1 |
Dalia, A; Hadjiconstantinou, M; Neff, NH | 1 |
Castagnoli, N; D'Engelbronner, J; Igarashi, K; Rollema, H; Skolnik, M; Usuki, E | 1 |
Cano, J; Santiago, M; Westerink, BH | 1 |
Ambrosio, S; Bartrons, R; Cutillas, B; Espino, A; Ferrer, I; Tortosa, A | 1 |
Cano, J; Granero, L; Machado, A; Santiago, M | 1 |
McBean, GJ; O'Byrne, MB; Tipton, KF | 1 |
Ambrosio, S; Bartrons, R; Cutillas, B; Espino, A | 1 |
Ali, SF; Cadet, JL; Freyaldenhoven, TE | 1 |
Cano, J; Machado, A; Millan, F; Revuelta, M; Romero-Ramos, M; Venero, JL | 1 |
Hikosaka, O; Horikawa, HP; Nakazato, T | 1 |
Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
Ambrosio, S; Cutillas, B; Espejo, M | 1 |
Beal, MF; Hyman, BT; Klockgether, T; Liao, AW; Martinou, JC; Matthews, RT; Penney, JB; Schulz, JB; Yang, L | 1 |
Ambrosio, S; Cutillas, B; Espejo, M; Llorens, J | 1 |
Andreassen, OA; Beal, MF; Bonventre, JV; Chin, MR; Ferrante, RJ; Klivenyi, P; Wermer, M | 1 |
Flint Beal, M; Klivenyi, P; Oberley, T; St Clair, D; Wermer, M; Yang, L; Yen, HC | 1 |
Cano, J; Machado, A; Merino, M; Vizuete, ML | 1 |
Hindmarsh, JG; Jenner, P; Rose, S | 1 |
Castagnoli, K; Castagnoli, N; Palmer, S | 1 |
Barja, G; Fabre, E; Herrero, A; Leret, ML; Monserrat, J | 1 |
Almendral, JM; Del Río, J; Frechilla, D; García-Osta, A; Insausti, R; Rubio, MP; Ruiz-Golvano, P | 1 |
Andreassen, OA; Beal, MF; Ferrante, RJ; Klivenyi, P; Lancelot, E; Reif, D | 1 |
Disshon, KA; Dluzen, DE | 1 |
Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A | 1 |
Arvin, M; Disshon, KA; Dluzen, DE; Fedorkova, L; Leipheimer, RE | 1 |
Kim, S; McCann, UD; Ricaurte, GA; Xie, T; Yuan, J | 1 |
Ferger, B; Teismann, P | 1 |
O'Byrne, MB; Tipton, KF | 1 |
Cory-Slechta, DA; Di Monte, DA; Langston, JW; Manning-Bog, AB; McCormack, AL; Thiffault, C; Thiruchelvam, M | 1 |
Cheng, XX; Han, JS; He, QH; Li, FQ; Liang, XB; Wang, XH; Wang, XM; Xue, B | 1 |
Battaglia, G; Biagioni, F; Bruno, V; Busceti, CL; Fornai, F; Molinaro, G; Nicoletti, F; Storto, M | 1 |
Gramsbergen, JB; Jakobsen, B; Møller Dall, A; Rosenblad, C; Zimmer, J | 1 |
Cui, Y; Jia, J; Luo, D; Sun, Z; Wang, H; Wang, X; Yang, J; Yu, F; Zhang, Q; Zheng, Y | 1 |
Nakayama, H; Sai, T; Uchida, K | 1 |
Chen, T; Hou, R; Li, C; Wu, C; Xu, S | 1 |
Chan, HM; Shao, Y | 1 |
70 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Homovanillic Acid; Kinetics; Male; N-Methylaspartate; Neurotoxins; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Trace dosages of the neurotoxins MPTP and MPP+ may affect brain dopamine in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Male; Mice; Mice, Inbred C57BL; Reserpine | 1992 |
Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Dialysis; Dopamine; Electrochemistry; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neurons; Rats; Rats, Inbred Strains; Substantia Nigra | 1991 |
Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Kinetics; Rats | 1991 |
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Mice; Motor Activity; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Phenethylamines; Pyridinium Compounds; Selegiline; Serotonin | 1985 |
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Pyridines; Pyridinium Compounds; Rats; Serotonin; Substantia Nigra | 1985 |
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Neurotransmitter Agents; Oxidopamine; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Substantia Nigra | 1986 |
Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Desipramine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Nomifensine; Pyridines; Pyridinium Compounds; Selegiline; Serotonin | 1987 |
MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Lactates; Lactic Acid; Male; Pyridinium Compounds; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Biogenic Monoamines; Corpus Striatum; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neurotoxins; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Calcium; Corpus Striatum; Dialysis; Dopamine; Glutamates; Glutamic Acid; Haloperidol; Magnesium; Male; Nomifensine; Ouabain; Piperazines; Potassium; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tetrodotoxin | 1989 |
Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Strains; Species Specificity | 1989 |
Retinal dopamine sensitivity to MPP+ toxicity: electrophysiological and biochemical evaluation.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Vessels; Dopamine; Dose-Response Relationship, Drug; Electroretinography; Eye; Injections; Rabbits; Retina | 1989 |
1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Neurons; Neurotoxins; Receptors, Dopamine; Synaptosomes | 1989 |
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Neurotoxins; Neurotransmitter Uptake Inhibitors; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reserpine; Time Factors | 1988 |
Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Pyridines; Pyridinium Compounds; Receptors, Dopamine; Selegiline | 1987 |
Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Calcium; Corpus Striatum; Dopamine; Kinetics; Male; Neurotoxins; Ouabain; Perfusion; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reference Values; Sodium | 1988 |
In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Carbolines; Corpus Striatum; Dialysis; Dopamine; Male; Nervous System Diseases; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Infusions, Parenteral; Kinetics; Male; Neurotoxins; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1987 |
The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Interactions; Male; Perfusion; Potassium; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1986 |
Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Herbicides; Homovanillic Acid; Male; Neurons; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1986 |
Tissue culture model for studying MPTP toxicity to dopamine neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Culture Techniques; Dopamine; Homovanillic Acid; Mesencephalon; Neurons; Pyridines; Pyridinium Compounds; Rats; Receptors, Dopamine | 1987 |
The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Male; Morphine; Neurotoxins; Nucleus Accumbens; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Septal Nuclei; Tetrodotoxin | 1987 |
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Pyridines; Pyridinium Compounds; Substantia Nigra | 1985 |
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Rats; Rats, Wistar | 1993 |
(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Ditiocarb; Dizocilpine Maleate; Dopamine; Drug Synergism; Haplorhini; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Piperazines; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 1995 |
Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Image Processing, Computer-Assisted; Injections; Male; Neostriatum; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1995 |
Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase; Neostriatum; Neurons; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Estrus; Female; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neostriatum; Sex Characteristics | 1994 |
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles | 1994 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Guanethidine; Male; Mice; Microdialysis; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neurons; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptosomes | 1994 |
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dose-Response Relationship, Drug; Guanethidine; Male; Mice; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity | 1994 |
GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Cells, Cultured; Cytarabine; Dopamine; G(M1) Ganglioside; Gestational Age; Immunohistochemistry; Kinetics; Mesencephalon; Neuroglia; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 1993 |
MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Haloperidol; Lactates; Lactic Acid; Male; Mice; Microdialysis; Mitochondria, Liver; Nervous System; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Serotonin | 1994 |
Are bilateral nigrostriatal dopaminergic pathways functionally linked in the rat brain? A microdialysis study in conscious rats.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Corpus Striatum; Dopamine; Kainic Acid; Male; Microdialysis; Muscimol; Neural Pathways; Picrotoxin; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission; Tetrodotoxin | 1993 |
Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dopamine Agents; Extracellular Space; Homovanillic Acid; Immunohistochemistry; Injections; Male; Microdialysis; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics | 1995 |
Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Nomifensine; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Uncoupling Agents | 1995 |
The effects of 1-methyl-4-phenylpyridinium ion on biogenic amine levels in rat substantia nigra.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Catecholamines; Chromatography, High Pressure Liquid; Dopamine; Female; Homovanillic Acid; In Vitro Techniques; Neurotoxins; Norepinephrine; Rats; Rats, Wistar; Serotonin; Substantia Nigra | 1996 |
Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Male; Neurotoxins; Nomifensine; Perfusion; Rats; Rats, Wistar; Substantia Nigra | 1996 |
MPP+ toxicity in rat striatal slices: relationship between non-selective effects and free radical production.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Free Radicals; In Vitro Techniques; Malondialdehyde; Rats; Rats, Sprague-Dawley | 1996 |
The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Female; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Sex Characteristics; Time Factors | 1996 |
Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Ascorbic Acid Deficiency; Body Weight; Central Nervous System Diseases; Dehydroascorbic Acid; Dopamine; Dopamine Agents; Female; Guinea Pigs; Homovanillic Acid; Neostriatum; Organ Culture Techniques; Tyrosine 3-Monooxygenase; Uric Acid | 1997 |
Duration of catalepsy correlates with increased intrastriatal sulpiride.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electrochemistry; Homovanillic Acid; Male; Microinjections; Neostriatum; Rats; Rats, Sprague-Dawley; Sulpiride; Time Factors | 1997 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
7-Nitroindazole prevents dopamine depletion caused by low concentrations of MPP+ in rat striatal slices.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Indazoles; Male; Rats; Rats, Sprague-Dawley | 1998 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Apoptosis; Brain Chemistry; Caspase 2; Caspase Inhibitors; Caspases; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Free Radicals; Gene Expression; Homovanillic Acid; Injections, Intraperitoneal; Male; Mazindol; Mice; Mice, Transgenic; MPTP Poisoning; Neurons; Neurotoxins; Oxidative Stress; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Radioligand Assay; Tritium; Tyrosine | 1998 |
Intrastriatal grafts of fetal mesencephalic cell suspensions in MPP+-lesioned rats: a microdialysis study in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Fetal Tissue Transplantation; Homovanillic Acid; Immunohistochemistry; Male; Mesencephalon; Microdialysis; Rats; Rats, Sprague-Dawley | 1998 |
Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Count; Corpus Striatum; Cytosol; Dopamine Agents; Drug Resistance; Homovanillic Acid; Mice; Mice, Knockout; Neurotoxins; Phospholipases A; Phospholipases A2; Substantia Nigra; Tyrosine 3-Monooxygenase | 1998 |
Manganese superoxide dismutase overexpression attenuates MPTP toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Cerebral Cortex; Dopamine; Dopamine Agents; Gene Expression; Humans; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Mitochondria; Neurons; Superoxide Dismutase; Transgenes | 1998 |
The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Kynurenic Acid; Microinjections; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase | 1999 |
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Indazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar | 1999 |
Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cattle; Corpus Striatum; Dopamine; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Neurotoxins; Selegiline | 1999 |
Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Brain; Corpus Striatum; Dopamine; Hydrogen Peroxide; Male; MPTP Poisoning; Oxidative Stress; Rats; Rats, Wistar | 1999 |
Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Galactosidase; Brain-Derived Neurotrophic Factor; Cell Line; Cell Transplantation; Cerebral Cortex; Corpus Striatum; Denervation; Dopamine; Fibroblasts; Gene Library; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Neurotoxins; Protein Precursors; Rats; Recombinant Proteins; Serotonin; Transfection | 2000 |
Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoquinolines; Male; Mice; MPTP Poisoning; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Substantia Nigra; Tetrahydroisoquinolines; Thiophenes; Tyrosine 3-Monooxygenase | 2000 |
Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estrogens; Extracellular Space; Female; Herbicides; Male; Microdialysis; Nerve Degeneration; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2000 |
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone | 2000 |
Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estrogens; Female; In Vitro Techniques; Microelectrodes; Microinjections; Neurons; Neuroprotective Agents; Nucleus Accumbens; Ovariectomy; Oxidation-Reduction; Perfusion; Rats | 2000 |
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Brain; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intracellular Fluid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Neuroblastoma; Neurons; Rats; Rats, Sprague-Dawley; Temperature | 2000 |
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Homovanillic Acid; Isoenzymes; Male; Meloxicam; Membrane Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Prostaglandin-Endoperoxide Synthases; Substantia Nigra; Thiazines; Thiazoles; Tyrosine 3-Monooxygenase | 2001 |
Inhibition of the neuronal isoform of nitric oxide synthase significantly attenuates 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in vitro.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; In Vitro Techniques; Indazoles; L-Lactate Dehydrogenase; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroarginine; Rats; Rats, Wistar | 2002 |
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Environmental Exposure; gamma-Aminobutyric Acid; Gliosis; Herbicides; Homovanillic Acid; Humans; Injections, Intraperitoneal; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Axotomy; Brain-Derived Neurotrophic Factor; Cell Division; Cells, Cultured; Corpus Striatum; Diterpenes; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Homovanillic Acid; Immunohistochemistry; Immunosuppressive Agents; Medial Forebrain Bundle; Neurites; Neurons; Neuroprotective Agents; Phenanthrenes; Rats; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Tripterygium | 2003 |
Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Homovanillic Acid; Mice; Mice, Knockout; MPTP Poisoning; Neuroprotective Agents; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Substantia Nigra; Survival Rate; Synaptosomes | 2004 |
Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Differentiation; Cell Proliferation; Cell Size; Cells, Cultured; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Growth Factors; Neurons; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2005 |
Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Cell Death; Cell Line; Dopamine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Neurons; Neuroprotective Agents; Polysaccharides; Tyrosine 3-Monooxygenase | 2009 |
Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Brain; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Homovanillic Acid; Injections, Intraperitoneal; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Pregnancy; Tyrosine 3-Monooxygenase | 2013 |
MPTP/MPP+ suppresses activation of protein C in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antigens, CD; Brain; Cells, Cultured; Dopamine; Endothelial Cells; Endothelial Protein C Receptor; Glial Fibrillary Acidic Protein; HEK293 Cells; Humans; Male; Mice, Inbred C57BL; Microvessels; MPTP Poisoning; Nerve Tissue Proteins; Protein C; Receptors, Cell Surface; RNA, Small Interfering; Sp1 Transcription Factor; Thrombomodulin | 2015 |
Effects of methylmercury on dopamine release in MN9D neuronal cells.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Cell Line; Cell Survival; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Environmental Pollutants; Gene Expression Regulation; Homovanillic Acid; Kinetics; Methylmercury Compounds; Mice; Monoamine Oxidase; Nerve Tissue Proteins; RNA, Messenger; Tyrosine 3-Monooxygenase | 2015 |